The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele
nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation …

Extensive migration has led to the necessity of knowledge regarding the treatment of
migrants with different ethnical backgrounds. This is especially relevant for pharmacological …

Abstract Pharmacogenetic variation in Latin Americans is understudied, which sets a barrier
for the goal of global precision medicine. The RIBEF-CEIBA Network Consortium was …

We present the distribution of CYP 2D6, CYP 2C9, and CYP 2C19 variants and predicted
phenotypes in 33 native and admixed populations from Ibero‐America (n> 6,000) in the …

We present allele frequencies involving 39 pharmacogenetic biomarkers studied in Brazil,
and their distribution on self-reported race/color categories that:(1) involve a mix of …

Congress of Pharmacogenetics and Personalized Medicine. Ethnicity, clinical
implementation and regulatory environment (MESTIFAR 2016 Quito) Quito, Ecuador, 19–21 …

Precision medicine seeks to individualize the dose from the beginning of pharmacological
therapy based on the characteristics of each patient, genes involved in the metabolic …

Introduction CYP2C19 is a highly polymorphic gene responsible for metabolizing commonly
used drugs. CYP2C19* 2,* 3 (loss of activity alleles) and* 17 (increased activity allele) are …

Aim: The present review was aimed at analyzing the pharmacogenetic scientific activity in
Central America and the Caribbean. Materials & methods: A literature search for …

El proyecto HapMap ha generado información y preguntas sobre la diversidad genética en
las distintas pobla-ciones del mundo. En las últimas décadas, proyectos como la …